Low Residue Diet During 3 Days vs 1 Day Prior Colonoscopy
NCT ID: NCT03763266
Last Updated: 2020-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
858 participants
INTERVENTIONAL
2018-12-06
2020-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The role of diet in preparing for colonoscopy is not fully established. Currently there is not enough evidence available to choice between 3 days of low residue diet versus 1 day.
The research hypothesis is that the low residue diet offers a non-inferior bowel preparation and an improved tolerance.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3-day vs. 1-day Low Residue Diet Influence in Colonoscopy Preparation and Patient Tolerability
NCT02955901
a Low-residue Diet for Bowel Preparation
NCT03943758
Diet Selection Pre-Colonoscopy: Comparison Between Clear, Low-residue and Regular Diet
NCT03681444
A Trial Comparing Breakfast Versus no Breakfast Prior to Colonoscopy
NCT01454388
Efficacy of Low-residue Full Nutritive Formula Powder in Bowel Preparation for Colonoscopy
NCT06514989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 day low residue diet
Patients are instructed to complete a low residue diet exclusively one day prior the colonoscopy.
1 day low residue diet
Patients are interviewed and instructed by a nurse prior the colonoscopy. They receive oral and written dietary information. In case of morbidity associated with bad preparation they are given bisacodyl the night before the colonoscopy.
3 days low residue diet
Patients are instructed to complete a low residue diet three days prior the colonoscopy.
3 day low residue diet
Patients are interviewed and instructed by a nurse prior the colonoscopy. They receive oral and written dietary information. In case of morbidity associated with bad preparation they are given bisacodyl the night before the colonoscopy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1 day low residue diet
Patients are interviewed and instructed by a nurse prior the colonoscopy. They receive oral and written dietary information. In case of morbidity associated with bad preparation they are given bisacodyl the night before the colonoscopy.
3 day low residue diet
Patients are interviewed and instructed by a nurse prior the colonoscopy. They receive oral and written dietary information. In case of morbidity associated with bad preparation they are given bisacodyl the night before the colonoscopy.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
50 Years
69 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Parc Taulí Hospital Universitari
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Salvador Machlab
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva Martínez, PhD
Role: STUDY_DIRECTOR
Corporació Sanitaria Parc Taulí
Salvador Machlab, MD
Role: PRINCIPAL_INVESTIGATOR
Corporació Sanitaria Parc Taulí
Rafel Campo, PhD
Role: STUDY_DIRECTOR
Corporació Sanitaria Parc Taulí
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Parc Taulí
Sabadell, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017308
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.